Mitigating Risk Through Product Characterization

In this webinar, multiple approaches to characterizing the physico-chemical and structural attributes of therapeutic mAbs is presented with a focus on how it influences the resulting biological activity.

• Characterization of therapeutic antibodies
  • what, why, and when
  • Benefits of early use of PC approaches to understand your product
• Complexities of monoclonal (mAbs) and their characterization
• Approaches to characterization of mAb physico-chemical and structural attributes
• Functional characterization of mAbs